J.B. Chemicals & Pharmaceuticals Limited (JB Pharma) has released its Business Responsibility and Sustainability Report for the financial year 2025-26. The report highlights the company’s commitment to Environment, Social, and Governance (ESG) initiatives, detailing progress on renewable energy adoption, waste management, and social impact projects. With significant growth in the domestic market and global exports, JB Pharma continues to integrate sustainable practices into its manufacturing and corporate operations.
Financial and Operational Highlights
During FY 2025-26, JB Pharma demonstrated robust performance, reporting consolidated revenue from operations of INR 4,14,779 lakhs. The company remains a prominent leader in the cardiology segment and has expanded its global footprint, exporting finished formulations to over 40 countries. The company operates eight advanced manufacturing facilities in India, all certified by international regulatory authorities.
Sustainability Commitments and Progress
The company has defined clear ESG goals to guide its long-term strategy. Key achievements include sourcing 36,580,599.53 kWh of electricity from renewable sources and achieving zero liquid discharge (ZLD) at all manufacturing sites. JB Pharma has set ambitious targets, including achieving carbon neutrality in direct operations (Scope 1 and 2) by FY 2032-33 and meeting 100% of its power demand through renewable energy by the same year.
Commitment to People and Community
JB Pharma’s “People First” philosophy is reflected in its workforce initiatives. In FY 2025-26, the company invested in continuous learning and safety, maintaining zero fatalities across its operations. Furthermore, the company has deeply engaged with communities through various Corporate Social Responsibility (CSR) projects, including healthcare access, girl child education, and providing clean drinking water, directly benefiting thousands of individuals from vulnerable and marginalized groups.
Governance and Ethics
JB Pharma maintains a strong governance framework, overseen by the Board of Directors through specialized committees. The company has successfully implemented Anti-Corruption and Bribery Policies and a Whistleblower mechanism to ensure transparency and ethical conduct. All policies are reviewed annually, reinforcing the company’s dedication to responsible business conduct and compliance with high ethical standards.
Source: BSE
